Palladium-103 plaque brachytherapy for retinoblastoma: Long term follow up [PDF]
American Journal of Ophthalmology Case Reports, 2022 Purpose: Radiation has been used in the treatment of retinoblastoma. Herein, we present the novel use of palladium-103 plaque brachytherapy as primary treatment.
Abhilasha Maheshwari, Paul T Finger
exaly +5 more sources
Plaque brachytherapy – Radiating positivity [PDF]
Indian Journal of Ophthalmology, 2023 Background: Plaque brachytherapy is an evolving, yet effective globe and vision-sparing modality for the treatment of intraocular tumors by transscleral irradiation of the tumor base with a radioactive implant.
Rolika Bansal +3 more
doaj +4 more sources
Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma [PDF]
American Journal of Ophthalmology Case Reports, 2022 Purpose: To report successful ring-shaped iodine-125 plaque brachytherapy for conjunctival melanoma. Observations: Eye Physics (EP) plaque brachytherapy, designed with Plaque Simulator software, proved to be an effective treatment modality with some ...
Sean T Berkowitz +2 more
exaly +4 more sources
Disinsert, retract and rotate technique of plaque brachytherapy [PDF]
Indian Journal of OphthalmologyBackground: Plaque brachytherapy is commonly used in the management of choroidal melanomas. The surgical steps usually involve creating a conjunctival peritomy, fixing the recti muscles, with or without disinserting them based on the location of the ...
Neiwete Lomi +2 more
doaj +4 more sources
Plaque Brachytherapy for DICER1-Associated Ciliary Body Medulloepithelioma [PDF]
Journal of Current OphthalmologyPurpose: To report the outcome of a ciliary body medulloepithelioma associated with DICER-1 syndrome treated with iodine-125 plaque brachytherapy. Methods: An 11-year-old male with a DICER1 gene mutation, who was previously treated for pineoblastoma with
Mojtaba Abrishami +2 more
doaj +5 more sources
Association of female sex with cataract surgery in the general population but not in plaque brachytherapy-treated uveal melanoma patients [PDF]
Scientific ReportsCataract is a leading cause of blindness worldwide, necessitating a deeper understanding of its risk factors. We analyzed two cohorts: 1000 individuals from the general Swedish population and 933 patients who received plaque brachytherapy for uveal ...
Anna Hagström +3 more
doaj +4 more sources
Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning [PDF]
Frontiers in Medicine, 2022 IntroductionUveal melanoma (UM) is the most common intraocular malignancy in adults. Plaque brachytherapy remains the dominant eyeball-conserving therapy for UM. Tumor regression in UM after plaque brachytherapy has been reported as a valuable prognostic
Yu-Ning Chen +2 more
exaly +4 more sources
Yttrium-90 Episcleral Plaque Brachytherapy for Choroidal Melanoma. [PDF]
J Vitreoretin DisPurpose: To describe the first use of high-dose-rate yttrium-90 disc brachytherapy for choroidal melanoma. Methods: A 72-year-old patient had a cT1-category choroidal melanoma characterized by the presence of orange pigment, increasing subretinal fluid (SRF), and enlarging tumor thickness.
Finger PT.
europepmc +5 more sources
106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma [PDF]
Radiation Oncology, 2020 Background To evaluate 106Ruthenium Brachytherapy in management of medium sized uveal melanoma, with emphasis on 5-year outcome and toxicity. Methods From April 2007 to October 2015, 39 patients with medium sized uveal melanoma were treated with 106 Ru ...
Ping Jiang +7 more
doaj +4 more sources
Complications and adverse events of plaque brachytherapy for ocular melanoma [PDF]
Journal of Contemporary Brachytherapy, 2019 Plaque brachytherapy is a well-accepted modality to manage selected cases of ocular melanoma. Although this modality provides validated oncologic and quality of life benefits, severe complications and adverse events can occur.
Krishi Peddada +3 more
doaj +5 more sources